Early Aortic Valve Lipoprotein(a) Lowering Trial

clinical trial

MedicalStudy clinical_trial Q64611659

Press Enter · cited answer in seconds

Summary

Early Aortic Valve Lipoprotein(a) Lowering Trial is a clinical trial^[1].

Key Facts

Early Aortic Valve Lipoprotein(a) Lowering Trial is in the country of Canada^[2].
Early Aortic Valve Lipoprotein(a) Lowering Trial's instance of is recorded as clinical trial^[3].
Early Aortic Valve Lipoprotein(a) Lowering Trial's start time is recorded as +2014-05-31T00:00:00Z^[4].
Early Aortic Valve Lipoprotein(a) Lowering Trial's end time is recorded as +2017-01-31T00:00:00Z^[5].
Early Aortic Valve Lipoprotein(a) Lowering Trial's main subject is recorded as aortic valve stenosis^[6].
Early Aortic Valve Lipoprotein(a) Lowering Trial's number of participants is recorded as {'unit': '1', 'amount': '+238'}^[7].
Early Aortic Valve Lipoprotein(a) Lowering Trial's title is recorded as A Pilot,Randomized Controlled-trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease-translating Genomic Knowledge for Cardiovascular Prevention^[8].
Early Aortic Valve Lipoprotein(a) Lowering Trial's short name is recorded as EAVaLL^[9].
Early Aortic Valve Lipoprotein(a) Lowering Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}^[10].
Early Aortic Valve Lipoprotein(a) Lowering Trial's ClinicalTrials.gov ID is recorded as NCT02109614^[11].
Early Aortic Valve Lipoprotein(a) Lowering Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+85'}^[12].
Early Aortic Valve Lipoprotein(a) Lowering Trial's research intervention is recorded as niacinamide^[13].
Early Aortic Valve Lipoprotein(a) Lowering Trial's research intervention is recorded as nicotinic acid^[14].
Early Aortic Valve Lipoprotein(a) Lowering Trial's clinical trial phase is recorded as phase I clinical trial^[15].
Early Aortic Valve Lipoprotein(a) Lowering Trial's research site is recorded as Jewish General Hospital^[16].
Early Aortic Valve Lipoprotein(a) Lowering Trial's study type is recorded as interventional study^[17].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

End timeP582

2017-09 2026-09-26 Wikidata lists 2017-01-31 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country Canada

Short name EAVaLL

Properties

Clinical trial phase phase I clinical trial

End time January 31, 2017

Imported from wholeness_audit_2026-05-02

Main subject aortic valve stenosis

Maximum age 85 year

Minimum age 50 year

Number of participants 238

Research intervention niacinamide, nicotinic acid

Research site Jewish General Hospital

Start time May 31, 2014

Study type interventional study

Title A Pilot,Randomized Controlled-trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease-translating Genomic Knowledge for Cardiovascular Prevention

External References (1)

Clinicaltrials.gov id NCT02109614

🏷️ Also known as

en Early Aortic Valve Lipoprotein(a) Lowering Trial

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ Early Aortic Valve Lipoprotein(a) Lowering Trial is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). Early Aortic Valve Lipoprotein(a) Lowering Trial. Retrieved May 3, 2026, from https://4ort.xyz/entity/early-aortic-valve-lipoprotein-a-lowering-trial

MLA

“Early Aortic Valve Lipoprotein(a) Lowering Trial.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/early-aortic-valve-lipoprotein-a-lowering-trial.

BibTeX

@misc{4ortxyz_early-aortic-valve-lipoprotein-a-lowering-trial_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Early Aortic Valve Lipoprotein(a) Lowering Trial}}, year = {2026}, url = {https://4ort.xyz/entity/early-aortic-valve-lipoprotein-a-lowering-trial}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Early Aortic Valve Lipoprotein(a) Lowering Trial — https://4ort.xyz/entity/early-aortic-valve-lipoprotein-a-lowering-trial (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/early-aortic-valve-lipoprotein-a-lowering-trial · Last refreshed: May 3, 2026